David M Dingli, MD, PhD

  • 13891 Citations
  • 59 Scopus h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Evolutionary Game Dynamics and Cancer

Pacheco, J. M., Levin, S. A. & Dingli, D., Jan 1 2019, (Accepted/In press) In : Trends in Cancer.

Research output: Contribution to journalReview article

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

Russell, S. J., Babovic-Vuksanovic, D., Bexon, A., Cattaneo, R., Dingli, D., Dispenzieri, A., Deyle, D. R., Federspiel, M. J., Fielding, A., Galanis, E., Lacy, M. Q., Leibovich, B. C., Liu, M. C., Muñoz-Alía, M., Miest, T. C., Molina, J. R., Mueller, S., Okuno, S. H., Packiriswamy, N., Peikert, T. & 6 others, Raffel, C., Van Rhee, F., Ungerechts, G., Young, P. R., Zhou, Y. & Peng, K. W., Sep 2019, In : Mayo Clinic proceedings. 94, 9, p. 1834-1839 6 p.

Research output: Contribution to journalReview article

Open Access
3 Scopus citations

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W. I., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T. V., Lacy, M. Q., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W. J., Rajkumar, S. V., Kumar, S. K., Gertz, M. A. & Roy, V., Mar 1 2019, In : Bone Marrow Transplantation. 54, 3, p. 353-367 15 p.

Research output: Contribution to journalReview article

22 Scopus citations
2018

Monoclonal gammopathy of significance

Dingli, D. M., Jan 1 2018, In : Malta Medical Journal. 30, 2, p. 48-56 9 p.

Research output: Contribution to journalReview article

Therapy for relapsed multiple myeloma

Aljama, M. A., Sidiqi, M. H. & Dingli, D. M., Dec 1 2018, In : Panminerva Medica. 60, 4, p. 174-184 11 p.

Research output: Contribution to journalReview article

2017

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

Dingli, D. M., Ailawadhi, S., Bergsagel, P. L., Buadi, F. K., Dispenzieri, A., Fonseca, R., Gertz, M., Gonsalves, W., Hayman, S. R., Kapoor, P., Kourelis, T., Kumar, S. K., Kyle, R. A., Lacy, M., Leung, N., Lin, Y., Lust, J. A., Mikhael, J. R., Reeder, C. B., Roy, V. & 7 others, Russell, S. J., Sher, T., Stewart, A. K., Warsame, R., Zeldenrust, S. R., Rajkumar, S. V. & Chanan Khan, A. A., Apr 1 2017, In : Mayo Clinic Proceedings. 92, 4, p. 578-598 21 p.

Research output: Contribution to journalReview article

54 Scopus citations
2013
52 Scopus citations

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Kumar, S. K., Dingli, D., Leung, N., Hogan, W. J., Buadi, F. K. & Hayman, S. R., Apr 1 2013, In : Bone Marrow Transplantation. 48, 4, p. 557-561 5 p.

Research output: Contribution to journalReview article

110 Scopus citations

Second auto-SCT for treatment of relapsed multiple myeloma

Gonsalves, W. I., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Hayman, S. R., Buadi, F. K., Dingli, D., Hogan, W. J. & Kumar, S. K., Apr 1 2013, In : Bone Marrow Transplantation. 48, 4, p. 568-573 6 p.

Research output: Contribution to journalReview article

41 Scopus citations

Smoldering multiple myeloma requiring treatment: Time for a new definition?

Dispenzieri, A., Stewart, A. K., Chanan-Khan, A., Rajkumar, S. V., Kyle, R. A., Fonseca, R., Kapoor, P., Bergsagel, P. L., McCurdy, A., Gertz, M. A., Lacy, M. Q., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Reeder, C., Roy, V., Buadi, F., Dingli, D., Hayman, S. R., Leung, N. & 3 others, Lin, Y., Mikhael, J. & Kumar, S. K., Dec 19 2013, In : Blood. 122, 26, p. 4172-4181 10 p.

Research output: Contribution to journalReview article

56 Scopus citations
2011

Explaining the in vitro and in vivo differences in leukemia therapy

Lenaerts, T., Castagnetti, F., Traulsen, A., Pacheco, J. M., Rosti, G. & Dingli, D., May 15 2011, In : Cell Cycle. 10, 10, p. 1540-1544 5 p.

Research output: Contribution to journalReview article

7 Scopus citations
2010

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M. Q., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I. N. M., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M. A., Sep 2010, In : Mayo Clinic proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalReview article

106 Scopus citations
2009

Emerging therapies for multiple myeloma

David, D. & Rajkumar, S. V., Apr 2009, In : ONCOLOGY. 23, 5

Research output: Contribution to journalReview article

6 Scopus citations

Management of newly diagnosed symptomatic multiple myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

Kumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., Lacy, M. Q., Lust, J. A., Reeder, C. B., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J. & 2 others, Rajkumar, S. V. & Bergsagel, P. L., Dec 2009, In : Mayo Clinic proceedings. 84, 12, p. 1095-1110 16 p.

Research output: Contribution to journalReview article

197 Scopus citations
2006

Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia

Dingli, D. & Tefferi, A., Apr 1 2006, In : Current Hematologic Malignancy Reports. 1, 2, p. 69-74 6 p.

Research output: Contribution to journalReview article

9 Scopus citations
2005

A critical review of anagrelide therapy in essential thrombocythemia and related disorders

Dingli, D. & Tefferi, A., May 1 2005, In : Leukemia and Lymphoma. 46, 5, p. 641-650 10 p.

Research output: Contribution to journalReview article

18 Scopus citations
2004

Anagrelide: An update on its mechanisms of action and therapeutic potential

Dingli, D. & Tefferi, A., Aug 2004, In : Expert review of anticancer therapy. 4, 4, p. 533-541 9 p.

Research output: Contribution to journalReview article

4 Scopus citations

Myelofibrosis with myeloid metaplasia: New developments in pathogenesis and treatment

Dingli, D., Mesa, R. A. & Tefferi, A., Jul 1 2004, In : Internal Medicine. 43, 7, p. 540-547 8 p.

Research output: Contribution to journalReview article

38 Scopus citations
2003

In Vivo Imaging and Tumor Therapy with the Sodium Iodide Symporter

Ding, D., Russell, S. J. & Morris, J. C., Dec 15 2003, In : Journal of cellular biochemistry. 90, 6, p. 1079-1086 8 p.

Research output: Contribution to journalReview article

70 Scopus citations